Current options for the treatment of impetigo in children

Author： Sladden Michael J   Johnston Graham A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.13, 2005-10, pp. : 2245-2256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic and Localized Scleroderma in Children: Current and Future Treatment Options

By Rosenkranz Margalit E.   Agle Lucila M.A.   Efthimiou Petros   Lehman Thomas J.A.  

Pediatric Drugs, Vol. 8, Iss. 2, 2006-01 ,pp. : 85-97

Adis International

Access to resources Recommend Favorite

Refractory Idiopathic Immune Thrombocytopenic Purpura in Children: Current and Future Treatment Options

By Imbach P.  

Pediatric Drugs, Vol. 5, Iss. 12, 2003-01 ,pp. : 795-801

Adis International

Access to resources Recommend Favorite

Current treatment options for myeloma

By Terpos Evangelos   Rahemtulla Amin   Dimopoulos Meletios-Athanassios  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1127-1142

Informa Healthcare

Access to resources Recommend Favorite

Current treatment options for tendinopathy

By Maffulli Nicola   Longo Umile Giuseppe   Loppini Mattia   Denaro Vincenzo  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2177-2186

Informa Healthcare

Access to resources Recommend Favorite

Current treatment options for hyperprolactinemia

By Faje Alexander  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1611-1625

Informa Healthcare

Access to resources Recommend Favorite